SMID, D.E., F.M.E. FRANSSEN, M. GONIK, M. MIRAVITLLES, C. CASANOVA, B.G. COSIO, P. de LUCAS-RAMOS, J.M. MARIN, C. MARTINEZ, I. MIR, J.B. SORIANO, J.P. de TORRES, A. AGUSTI, N.B. ATALAY, J. BILLINGTON, A.K. BOUTOU, S. BRIGHENTI-ZOGG, E. CHAPLIN, S. COSTER, J.W. DODD, S. DURR, A. FERNANDEZ-VILLAR, M.T.J. GROENEN, M. GUIMARAES, Karel HEJDUK, V. HIGGINS, N.S. HOPKINSON, N. HORITA, S. HOUBEN-WILKE, D.J.A. JANSSEN, M. JEHN, R. JOERRES, A. KARCH, J.L. KELLY, Y.I. KIM, H. KIMURA, V. KOBLIZEK, J.H. KOCKS, S.S.C. KON, N. KWON, I. LADEIRA, S.D. LEE, J.D. LEUPPI, N. LOCANTORE, J.L. LOPEZ-CAMPOS, W.D.C. MAN, L. MARICIC, L. MENDOZA, D. MIEDINGER, F. MIHALTAN, S. MINAMI, T. van der MOLEN, T.J. MURRELLS, N. NAKKEN, Y. NISHIJIMA, I.J. NORMAN, B. NOVOTNA, D.E. O DONNELL, Y. OGATA, E.D. PEREIRA, J. PIERCY, D. PRICE, C. POTHIRAT, N. RAGHAVAN, T. RINGBAEK, D. SAJKOV, N. SIGARI, S. SINGH, M. SMALL, G.F. DA SILVA, R.J. TANNER, I.G. TSILIGIANNI, B. TULEK, N. TZANAKIS, L.E.G.W. VANFLETEREN, H. WATZ, K.A. WEBB, E.F.M. WOUTERS, G.G. XIE, M. YOSHIKAWA and M.A. SPRUIT. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. NEW YORK: ELSEVIER SCIENCE INC, 2017, vol. 18, No 12, p. 1-14. ISSN 1525-8610. Available from: https://dx.doi.org/10.1016/j.jamda.2017.09.003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Authors SMID, D.E. (528 Netherlands), F.M.E. FRANSSEN (528 Netherlands), M. GONIK (276 Germany), M. MIRAVITLLES (724 Spain), C. CASANOVA (724 Spain), B.G. COSIO (724 Spain), P. de LUCAS-RAMOS (724 Spain), J.M. MARIN (724 Spain), C. MARTINEZ (724 Spain), I. MIR (724 Spain), J.B. SORIANO (724 Spain), J.P. de TORRES (724 Spain), A. AGUSTI (724 Spain), N.B. ATALAY (792 Turkey), J. BILLINGTON (826 United Kingdom of Great Britain and Northern Ireland), A.K. BOUTOU (300 Greece), S. BRIGHENTI-ZOGG (756 Switzerland), E. CHAPLIN (826 United Kingdom of Great Britain and Northern Ireland), S. COSTER (826 United Kingdom of Great Britain and Northern Ireland), J.W. DODD (826 United Kingdom of Great Britain and Northern Ireland), S. DURR (756 Switzerland), A. FERNANDEZ-VILLAR (724 Spain), M.T.J. GROENEN (528 Netherlands), M. GUIMARAES (620 Portugal), Karel HEJDUK (203 Czech Republic, guarantor, belonging to the institution), V. HIGGINS (826 United Kingdom of Great Britain and Northern Ireland), N.S. HOPKINSON (826 United Kingdom of Great Britain and Northern Ireland), N. HORITA (392 Japan), S. HOUBEN-WILKE (528 Netherlands), D.J.A. JANSSEN (528 Netherlands), M. JEHN (276 Germany), R. JOERRES (276 Germany), A. KARCH (276 Germany), J.L. KELLY (826 United Kingdom of Great Britain and Northern Ireland), Y.I. KIM (410 Republic of Korea), H. KIMURA (392 Japan), V. KOBLIZEK (203 Czech Republic), J.H. KOCKS (528 Netherlands), S.S.C. KON (826 United Kingdom of Great Britain and Northern Ireland), N. KWON (826 United Kingdom of Great Britain and Northern Ireland), I. LADEIRA (620 Portugal), S.D. LEE (410 Republic of Korea), J.D. LEUPPI (756 Switzerland), N. LOCANTORE (840 United States of America), J.L. LOPEZ-CAMPOS (724 Spain), W.D.C. MAN (826 United Kingdom of Great Britain and Northern Ireland), L. MARICIC (191 Croatia), L. MENDOZA (152 Chile), D. MIEDINGER (756 Switzerland), F. MIHALTAN (642 Romania), S. MINAMI (392 Japan), T. van der MOLEN (528 Netherlands), T.J. MURRELLS (826 United Kingdom of Great Britain and Northern Ireland), N. NAKKEN (528 Netherlands), Y. NISHIJIMA (392 Japan), I.J. NORMAN (826 United Kingdom of Great Britain and Northern Ireland), B. NOVOTNA (203 Czech Republic), D.E. O DONNELL (124 Canada), Y. OGATA (392 Japan), E.D. PEREIRA (76 Brazil), J. PIERCY (826 United Kingdom of Great Britain and Northern Ireland), D. PRICE (826 United Kingdom of Great Britain and Northern Ireland), C. POTHIRAT (764 Thailand), N. RAGHAVAN (124 Canada), T. RINGBAEK (208 Denmark), D. SAJKOV (36 Australia), N. SIGARI (368 Iraq), S. SINGH (826 United Kingdom of Great Britain and Northern Ireland), M. SMALL (826 United Kingdom of Great Britain and Northern Ireland), G.F. DA SILVA (76 Brazil), R.J. TANNER (826 United Kingdom of Great Britain and Northern Ireland), I.G. TSILIGIANNI (528 Netherlands), B. TULEK (300 Greece), N. TZANAKIS (528 Netherlands), L.E.G.W. VANFLETEREN (528 Netherlands), H. WATZ (528 Netherlands), K.A. WEBB (124 Canada), E.F.M. WOUTERS (528 Netherlands), G.G. XIE (156 China), M. YOSHIKAWA (392 Japan) and M.A. SPRUIT (528 Netherlands).
Edition JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, NEW YORK, ELSEVIER SCIENCE INC, 2017, 1525-8610.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30227 Geriatrics and gerontology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.325
RIV identification code RIV/00216224:14110/17:00099170
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jamda.2017.09.003
UT WoS 000416478400025
Keywords in English COPD; GOLD; health status; clinical significance
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 13:14.
Abstract
Background: Patients with chronic obstructive pulmonary disease (COPD) can be classified into groups A/C or B/D based on symptom intensity. Different threshold values for symptom questionnaires can result in misclassification and, in turn, different treatment recommendations. The primary aim was to find the best fitting cut-points for Global initiative for chronic Obstructive Lung Disease (GOLD) symptom measures, with an modified Medical Research Council dyspnea grade of 2 or higher as point of reference. Methods: After a computerized search, data from 41 cohorts and whose authors agreed to provide data were pooled. COPD studies were eligible for analyses if they included, at least age, sex, post-bronchodilator spirometry, modified Medical Research Council, and COPD Assessment Test (CAT) total scores. Main outcomes: Receiver operating characteristic curves and the Youden index were used to determine the best calibration threshold for CAT, COPD Clinical Questionnaire, and St. Georges Respiratory Questionnaire total scores. Following, GOLD A/B/C/D frequencies were calculated based on current cut-points and the newly derived cut-points. Findings: A total of 18,577 patients with COPD [72.0% male; mean age: 66.3 years (standard deviation 9.6)] were analyzed. Most patients had a moderate or severe degree of airflow limitation (GOLD spirometric grade 1, 10.9%; grade 2, 46.6%; grade 3, 32.4%; and grade 4, 10.3%). The best calibration threshold for CAT total score was 18 points, for COPD Clinical Questionnaire total score 1.9 points, and for St. Georges Respiratory Questionnaire total score 46.0 points. Conclusions: The application of these new cut-points would reclassify about one-third of the patients with COPD and, thus, would impact on individual disease management. Further validation in prospective studies of these new values are needed. (C) 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
PrintDisplayed: 18/7/2024 14:25